Background illustration for clinical trials search

Paid Clinical Trials Oklahoma City

Discover 572 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

for
Endometrial Cancer
Location: Oklahoma City OK, Tyler TX, Shreveport LA, Aurora CO,
Sponsor: BioNTech SE

Sex: Female

Age: 18+

Code: NCT06340568

Phase 3, Recruiting

Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

for
Advanced Ovarian Cancer
Location: Oklahoma City OK, Seattle WA
Sponsor: Allarity Therapeutics

Sex: Female

Age: 18+

Code: NCT03878849

Phase 2, Recruiting

Spine Radiosurgery for Symptomatic Metastatic Neoplasms

for
Metastatic Neoplasm to the Spine, Metastatic Neoplasm
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT05617716

Phase 2, Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Oklahoma City OK, Tulsa OK, Fort Worth TX, Tyler TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting

Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)

for
Prostate Cancer, Renal Cell Carcinoma (RCC)
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: Male

Age: 18 - 70+

Code: NCT06960798

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Oklahoma City OK, Irving TX, Omaha NE, San Antonio TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase 1, Recruiting

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

for
Breast Cancer, Lymphoma
Location: Oklahoma City OK, Tulsa OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT05921253

Early Phase 1, Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for
Ovarian Cancer, Non-small Cell Lung Cancer
Location: Oklahoma City OK, Irving TX, Fort Worth TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06303505

Phase 1, Phase 2, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Oklahoma City OK, Springfield MO, Overland Park KS,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: Oklahoma City OK, San Antonio TX, Houston TX, Denver CO,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase 1, Recruiting

ALPINE: Maintenance Letrozole/Abemaciclib

for
Endometrial Cancer, Recurrent Endometrial Cancer, TP53
Location: Oklahoma City OK, Aurora CO, Boston MA, Weymouth MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06366347

Phase 2, Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Oklahoma City OK, Dallas TX, Kansas City KS, Omaha NE,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Oklahoma City OK, Dallas TX, Kansas City MO, Austin TX,
Sponsor: Iambic Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06253871

Phase 1, Recruiting

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

for
KRAS G12C Mutation, KRAS G12S Mutation,
Location: Oklahoma City OK, San Antonio TX, Denver CO,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06720987

Phase 1, Recruiting

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

for
Infusion Reactions
Location: Oklahoma City OK, Dallas TX, Fort Worth TX, Omaha NE,
Sponsor: New York Blood Center

Sex: All

Age: 0+

Code: NCT01656603

Phase 2, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Oklahoma City OK, Wichita KS, Dallas TX, Westwood KS,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: Oklahoma City OK, Kansas City MO, Shreveport LA,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase 2, Recruiting

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for
Cervical Cancer
Location: Oklahoma City OK, Bedford TX, Dallas TX, Fort Worth TX,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT04831580

Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Oklahoma City OK, Houston TX, New Lenox IL,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase 2, Recruiting

Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)

for
Ductal Carcinoma In Situ
Location: Oklahoma City OK, Houston TX
Sponsor: Windy Hill Medical, Inc.

Sex: Female

Age: 18+

Code: NCT00669747

Phase 2, Recruiting